CN106107980A - 一种能增加体重、身长、骨钙含量和提高骨密度的骨关节保健品 - Google Patents
一种能增加体重、身长、骨钙含量和提高骨密度的骨关节保健品 Download PDFInfo
- Publication number
- CN106107980A CN106107980A CN201610485616.1A CN201610485616A CN106107980A CN 106107980 A CN106107980 A CN 106107980A CN 201610485616 A CN201610485616 A CN 201610485616A CN 106107980 A CN106107980 A CN 106107980A
- Authority
- CN
- China
- Prior art keywords
- bone
- parts
- calcium
- group
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 54
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 51
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 43
- 239000011575 calcium Substances 0.000 title claims abstract description 43
- 230000037182 bone density Effects 0.000 title claims abstract description 28
- 201000008482 osteoarthritis Diseases 0.000 title claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 102000008186 Collagen Human genes 0.000 claims abstract description 13
- 108010035532 Collagen Proteins 0.000 claims abstract description 13
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 9
- 229940071162 caseinate Drugs 0.000 claims abstract description 9
- 239000008267 milk Substances 0.000 claims abstract description 8
- 210000004080 milk Anatomy 0.000 claims abstract description 8
- 235000013336 milk Nutrition 0.000 claims abstract description 8
- MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 abstract description 13
- 239000000203 mixture Substances 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 230000004097 bone metabolism Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 108010048734 sclerotin Proteins 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 36
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 229910052799 carbon Inorganic materials 0.000 description 11
- 230000037396 body weight Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 230000001009 osteoporotic effect Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 3
- 241000272525 Anas platyrhynchos Species 0.000 description 2
- 206010039984 Senile osteoporosis Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 210000004409 osteocyte Anatomy 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 150000002301 glucosamine derivatives Chemical class 0.000 description 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610485616.1A CN106107980A (zh) | 2016-06-28 | 2016-06-28 | 一种能增加体重、身长、骨钙含量和提高骨密度的骨关节保健品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610485616.1A CN106107980A (zh) | 2016-06-28 | 2016-06-28 | 一种能增加体重、身长、骨钙含量和提高骨密度的骨关节保健品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106107980A true CN106107980A (zh) | 2016-11-16 |
Family
ID=57266911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610485616.1A Pending CN106107980A (zh) | 2016-06-28 | 2016-06-28 | 一种能增加体重、身长、骨钙含量和提高骨密度的骨关节保健品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106107980A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106858590A (zh) * | 2017-02-09 | 2017-06-20 | 南京庄泰生物技术有限公司 | 一种新型的骨关节保健品 |
CN107736612A (zh) * | 2017-10-24 | 2018-02-27 | 山东陆海蓝圣生物科技股份有限公司 | 氨糖骨钙胶囊产品配方及工艺 |
CN108295245A (zh) * | 2018-04-10 | 2018-07-20 | 湖南科技学院 | 增加骨密度药及胶囊剂制备方法 |
CN109432388A (zh) * | 2018-12-25 | 2019-03-08 | 上海交大昂立股份有限公司 | 一种益生菌和盐酸氨基葡萄糖的组合物及其在骨关节健康方面的应用 |
CN109805417A (zh) * | 2019-03-01 | 2019-05-28 | 河南九九一生物科技有限公司 | 一种能够增加骨密度的保健食品及其加工方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101015682A (zh) * | 2007-02-01 | 2007-08-15 | 甘肃奇正藏药有限公司 | 具有增加骨密度功能的药物组合物及制备和质量控制方法 |
CN101248882A (zh) * | 2008-03-28 | 2008-08-27 | 北京东方兴企食品工业技术有限公司 | 一种具有促进骨骼和骨关节健康的营养食品 |
CN102302116A (zh) * | 2011-06-10 | 2012-01-04 | 营养屋(成都)生物医药有限公司 | 一种补钙、锁钙保健食品及其制备方法 |
CN105412569A (zh) * | 2015-12-24 | 2016-03-23 | 福和寿(武汉)健康管理有限公司 | 一种增加骨密度的组合物及其制剂和制法 |
-
2016
- 2016-06-28 CN CN201610485616.1A patent/CN106107980A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101015682A (zh) * | 2007-02-01 | 2007-08-15 | 甘肃奇正藏药有限公司 | 具有增加骨密度功能的药物组合物及制备和质量控制方法 |
CN101248882A (zh) * | 2008-03-28 | 2008-08-27 | 北京东方兴企食品工业技术有限公司 | 一种具有促进骨骼和骨关节健康的营养食品 |
CN102302116A (zh) * | 2011-06-10 | 2012-01-04 | 营养屋(成都)生物医药有限公司 | 一种补钙、锁钙保健食品及其制备方法 |
CN105412569A (zh) * | 2015-12-24 | 2016-03-23 | 福和寿(武汉)健康管理有限公司 | 一种增加骨密度的组合物及其制剂和制法 |
Non-Patent Citations (1)
Title |
---|
宁莉: "《公共营养师 上》", 31 March 2015, 辽宁科学技术出版社 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106858590A (zh) * | 2017-02-09 | 2017-06-20 | 南京庄泰生物技术有限公司 | 一种新型的骨关节保健品 |
CN107736612A (zh) * | 2017-10-24 | 2018-02-27 | 山东陆海蓝圣生物科技股份有限公司 | 氨糖骨钙胶囊产品配方及工艺 |
CN108295245A (zh) * | 2018-04-10 | 2018-07-20 | 湖南科技学院 | 增加骨密度药及胶囊剂制备方法 |
CN109432388A (zh) * | 2018-12-25 | 2019-03-08 | 上海交大昂立股份有限公司 | 一种益生菌和盐酸氨基葡萄糖的组合物及其在骨关节健康方面的应用 |
CN109432388B (zh) * | 2018-12-25 | 2021-12-31 | 上海交大昂立股份有限公司 | 一种益生菌和盐酸氨基葡萄糖的组合物及其在骨关节健康方面的应用 |
CN109805417A (zh) * | 2019-03-01 | 2019-05-28 | 河南九九一生物科技有限公司 | 一种能够增加骨密度的保健食品及其加工方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106107980A (zh) | 一种能增加体重、身长、骨钙含量和提高骨密度的骨关节保健品 | |
JP2019516412A (ja) | 低分子コラーゲンペプチドおよびこれを用いた食品組成物の製造方法 | |
Moskowitz | Role of collagen hydrolysate in bone and joint disease | |
Bland | Canine osteoarthritis and treatments: a review | |
CN106235311A (zh) | 一种促进骨骼系统健康的组合物及其应用 | |
CN108378374A (zh) | 一种预防骨质疏松、促进骨健康的组合物 | |
CN101049157B (zh) | 一种具有预防骨质疏松作用的保健食品 | |
CN102753043A (zh) | 优化膳食酸-碱电位的营养组合物和方法 | |
Masarwi et al. | Skeletal effect of casein and whey protein intake during catch-up growth in young male Sprague–Dawley rats | |
CN106262809A (zh) | 一种增强骨密度缓解中老年关节疼痛的组合物 | |
CN105943958A (zh) | 一种治疗痛风的桦褐孔菌复合固体颗粒及其制备方法 | |
CN101167754A (zh) | 海洋骨原肽作为制备预防骨质疏松药物、保健食品或食品的用途 | |
CN102613559A (zh) | 一种复合蛋白粉胶囊及其制备方法 | |
CN104888192B (zh) | 一种增加骨密度的海参氨糖制剂及其生产方法 | |
Shim et al. | Randomized, double-blind, and placebo-controlled human trial to evaluate the efficacy and safety of Allium Fistulosum L. root extract on improvement of child height growth: study protocol | |
MARDIYONO et al. | The Effect of Chinese Cabbage and Key Lime Juice on Bone Mass Density in Premenopausal Women. | |
JP2018519322A (ja) | 海洋ペプチドおよび筋肉の健康 | |
JP2005232089A (ja) | 骨量増加作用を有する機能性経口投与剤 | |
CN111513313A (zh) | 一种增强骨密度的组合物及其制剂和制备方法 | |
JP2017039652A (ja) | メタボリックシンドロームの予防または改善のための食用組成物 | |
CN104814438A (zh) | 多种营养保健品 | |
CN105520135A (zh) | 一种具有治疗骨质疏松功能的保健食品 | |
Shawky et al. | Microcephalic osteodysplastic primordial dwarfism (MOPD) type I with severe anemia and MRI brain findings of MOPD type II | |
Wu et al. | Effect of high plant protein/peptide nutrition supplementation on knee osteoarthritis in older adults with sarcopenia: A randomized, double-blind, placebo-controlled trial | |
Sreelekshmi | Understanding Osteoporosis and its Ayurvedic Management-A Review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170519 Address after: Qing Ping Road Qingpu District Xujing town Shanghai City Luzhou 201700 No. 2008 floor 10 room 1025 Applicant after: SHANGHAI NO-TOP BIOTECHNOLOGY CO., LTD. Address before: 200030 Shanghai city Xuhui District Yunjin Road No. 500 Green Exchange Center B building 17 floor Applicant before: Zhang Biao |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190121 Address after: Room 503, 5th floor, Daye Plaza, Jingheng, 2008, Shanghai Qingpu District, Shanghai Applicant after: Shanghai Yuanding Biotechnology Co., Ltd. Address before: Room 1025, 10th floor, 2008 Luqingping Road, Xujing Town, Qingpu District, Shanghai Applicant before: SHANGHAI NO-TOP BIOTECHNOLOGY CO., LTD. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161116 |
|
RJ01 | Rejection of invention patent application after publication |